The fluocinolone acetonide implant could mean fewer hospital visits for patients who receive the current treatments.
The fluocinolone acetonide implant could mean fewer hospital visits for patients who receive the current treatments.
The partnership will focus on identifying and validating novel drug targets for unmet therapeutic needs for psychiatric symptoms affecting people with mental health conditions
The news coincides with the Medicines Manufacturing Industry Partnership (MMIP) annual conference.
The approval was based on data from the pivotal Phase III SOLO-1 trial.
Breathlessness affects 10% of the UK population and up to 30% of older people.
The collaboration will continue to develop new medicines that target and destroy key cancer causing proteins.
Liver cancer is the sixth bigger cancer killer in the EU, claiming the lives of almost 60,000 people per year.
Amgen has a confidential commercial arrangement which will make the drug available to the NHS with a discount.
The company announced a statistically significant and clinically meaningful improvement from its Phase IIIb DIALIZE trial.
The cancer-killing virus with immunotherapy could effectively treat the advanced cancers.
A final NHS People Plan will be published following the outcome of the Comprehensive Spending Review.
The collaboration will leverage deep analytics across data sets to better understand key diseases.
The company will use ‘Exogenous Volatile Organic Compound Probes’.
The Chelsea Harbour Hotel has been confirmed to host the gala dinner and awards ceremonies for the three competitions on 14th November.
A no-deal Brexit should be avoided ‘at any cost’, according to the College